HOw it works
Patented bioelectric signaling sequence for controlling OPG expression for osseointegration
Patent pending bioelectric sequence for controlling KLOTHO expression.
Patented bioelectric signaling sequence for controlling RANKL expression.
Patent pending bioelectric sequence for controlling IGF1 expression.
Patented combination of bioelectics and biologics for accelerated healing.
Patent pending bioelectric PRF combination.
- ImplantStim™ – Bioelectric stimulation controlled protein expressions for accelerated healing.
- ImplantStim™ Wireless – Wireless electromagnetic energy controlled protein expressions for accelerator healing .
- ImplantStim™ Plus – Bioelectric stimulation + IS-15 proprietary biologics composition for accelerated healing including patent pending Bioelectric PRF TM and regenerative fluid derived from amniotic fluid and exosomes.
Target Goals of the ImplantStim Therapy
- 70% Improvement of bone formation (osteogenesis)
- 400% Acceleration of the healing process via osteointegration by controlled bioelectric release of OPG and other healing promoting proteins.
- 70% Reduction of pain an discomfort
- 50% Increase in bone to implant (BIC)
- 70% Increase in trabecular bone volume density
- Reduce the need for repeat/repair surgeries